NY false 0001802768 0001802768 2022-06-23 2022-06-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to present at the Goldman...
NEW YORK, May 23, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it is...
NY false 0001802768 0001802768 2022-05-17 2022-05-17 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
New capital deployment target of $10-12 billion over the next five yearsOutlook for 2020-2025 Adjusted Cash...
NY false 0001802768 0001802768 2022-05-10 2022-05-10 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
0001802768December 312022Q1FALSE44Subsequent Events]00018027682022-01-012022-03-310001802768us-gaap:CommonClassAMember2022-05-02xbrli:shares0001802...
0001802768false00018027682022-05-052022-05-05UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-K CURRENT REPORTPursuant...
Net cash provided by operating activities (GAAP) of $460 million; Adjusted Cash Receipts(1) (non-GAAP) of $605...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.